Are you Dr. Balmanoukian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 70 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-7911- Is this information wrong?
Summary
- Dr. Ani Balmanoukian, MD is an oncologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and California. She is affiliated with Providence Saint John's Health Center and Cedars-Sinai Medical Center.
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011
- Johns Hopkins UniversityResidency, Internal Medicine, 2005 - 2008
- New York Medical CollegeClass of 2005
Certifications & Licensure
- CA State Medical License 2011 - 2024
- MD State Medical License 2008 - 2012
Clinical Trials
- INCMGA00012 in Combination With Other Therapies in Patients With Advanced Solid Tumors Start of enrollment: 2018 Aug 17
Publications & Presentations
PubMed
- 3 citationsPertuzumab Plus Trastuzumab in Patients With Lung Cancer WithMutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study.Apar K Ganti, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Elie G Dib, Herbert L Duvivier, Eugene R Ahn, Deepti Behl, Hossein Borghaei, Ani S Balmanoukian, An...> ;JCO Precision Oncology. 2023 Jun 1
- 5 citationsPertuzumab Plus Trastuzumab in Patients With Endometrial Cancer WithAmplification, Overexpression, or Mutation: Results From the TAPUR Study.Eugene R Ahn, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Hussein M Ali-Ahmad, John Chan, Michael L Maitland, Sapna R Patel, Zachary Reese, Ani S Balmanoukia...> ;JCO Precision Oncology. 2023 Apr 1
- 7 citationsAmivantamab (JNJ-61186372) induces clinical, biochemical, molecular, and radiographic response in a treatment-refractory NSCLC patient harboring amplified triple EGFR ...Misako Nagasaka, Ani S Balmanoukian, Russell Madison, Samuel J Klempner, Sai-Hong Ignatius Ou, Zhang, S.> ;Lung Cancer. 2022 Feb 1
- Join now to see all
Press Mentions
- Presents State of Science SummitFebruary 21st, 2018
- ABMDR’s First Cancer Awareness Symposium Received with EnthusiasmSeptember 30th, 2016
- ABMDR’s First Cancer Awareness Symposium Received with EnthusiasmSeptember 30th, 2016
Hospital Affiliations
- Providence Saint John's Health CenterSanta Monica, California
- Cedars-Sinai Medical CenterLos Angeles, California